CC
GEN

Cannell Capital’s Genesis Healthcare, Inc. GEN Stock Holding History

Cannell Capital’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-968,910
Closed -$1.72M – 56
2016
Q2 		$1.72M Sell
968,910
-433,981
-31% -$885K 0.7% 33
2016
Q1 		$3.25M Sell
1,402,891
-304,169
-18% -$688K 1.37% 28
2015
Q4 		$5.92M Buy
1,707,060
+160,520
+10% +$769K 2.49% 15
2015
Q3 		$9.48M Buy
1,546,540
+60,589
+4% +$411K 3.55% 8
2015
Q2 		$9.81M Hold
1,485,951
– – 3.21% 10
2015
Q1 		$10.6M Buy
+1,485,951
New +$11.2M 3.31% 9

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Cannell Capital's GEN Position: Q3 2016 in Review

Cannell Capital sold out of Genesis Healthcare, Inc. (GEN) in Q3 2016, closing a stake of 968,910 shares — an estimated $1.72M sold.

Cannell Capital first reported a position in GEN in Q1 2015 and held it in 6 quarters. The position peaked at $10.6M in Q1 2015. 65 funds tracked by Wall St. Rank hold GEN as of Q3 2016.

  • Cannell Capital reported no remaining Genesis Healthcare, Inc. position as of Q3 2016 after selling out during the quarter.
  • Cannell Capital sold 968,910 Genesis Healthcare, Inc. shares in Q3 2016, an estimated $1.72M.
  • Cannell Capital first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 6 quarters.
  • Cannell Capital's Genesis Healthcare, Inc. position peaked at $10.6M in Q1 2015.
  • 65 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2016.

Based on Cannell Capital's 13F filing for Q3 2016, filed 15 Nov 2016.